Quandary about treatment of aspergillomas persists

Lancet

Volumn 347, Issue 9016, 1996, Pages 1640-

  Kauffman, C A ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOCAPROIC ACID; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; MICONAZOLE; NATAMYCIN; NYSTATIN; POTASSIUM IODIDE; SODIUM IODIDE;

ASPERGILLOSIS; COUGHING; HEMOPTYSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; SURGICAL MORTALITY; THORAX RADIOGRAPHY;

EID: 15844396180     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91481-6     Document Type: Article

References (6)

1. J. Jewkes Ph Kay M. Paneth Km Citron Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment Thorax 38 1983 572 578
2. P. Diot B. Rivoire A. Le Pape Deposition of amphotericin B aerosols in pulmonary aspergilloma Eur Respir J 8 1995 1263 1268
3. G. Massard N. Roeslin J-M. Wihlm P. Dumont J-P. Witz G. Morand Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment Ann Thorac Surg 54 1992 1159 1164
4. Hl Israel Gs Lenchner Gw Atkinson Sarcoidosis and aspergilloma: role of surgery Chest 82 1982 430 432
5. M. Rumbak G. Kohler C. Eastrige H. Winer-Muram M. Gavant Topical treatment of life threatening haemoptysis from aspergillomas Thorax 51 1996 253 255
6. H. Yamada S. Kohno H. Koga S. Maesaki M. Kaku Topical treatment of pulmonary aspergilloma by antifungals. Relationship between duration of the disease and efficacy of therapy Chest 103 1993 1421 1425